Menu
Back to Journals » OncoTargets and Therapy » Volume 7
Original Research
Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 17,294 | Dovepress* | 14,908+ | 2,095 | 17,003 | |
| PubMed Central* | 2,386 | 600 | 2,986 | ||
| Totals | 17,294 | 2,695 | 19,989 | ||
|
*Since 16 January 2014 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 7 | 0 | 0 | 0 | 3 | 4 |
View citations on PubMed Central and Google Scholar